69.75.050 – Preemption.
RCW 69.75.050 Preemption. This chapter preempts any ordinance regulating the sale, distribution, receipt, or possession of dextromethorphan enacted by a county, city, town, or other political subdivision of this state, and dextromethorphan is not subject to further regulation by such subdivisions. [ 2014 c 64 § 5.]
69.75.900 – Effective date—2014 c 64.
RCW 69.75.900 Effective date—2014 c 64. This act takes effect July 1, 2015. [ 2014 c 64 § 7.]
69.77.010 – Findings—Intent.
RCW 69.77.010 Findings—Intent. The legislature finds that the process for approval of investigational drugs, biological products, and devices in the United States protects future patients from premature, ineffective, and unsafe medications and treatments over time, but the process often takes many years. Patients who have a terminal illness do not have the luxury of waiting […]
69.77.020 – Definitions.
RCW 69.77.020 Definitions. The definitions in this section apply throughout this chapter unless the context clearly requires otherwise. (1) “Eligible patient” means an individual who meets the requirements of RCW 69.77.040. (2) “Health care facility” means a clinic, nursing home, laboratory, office, or similar place where a health care provider provides health care to patients. […]
69.77.030 – Eligible patient and treating physician may request investigational product—Manufacturer may make for treatment—Agreement.
RCW 69.77.030 Eligible patient and treating physician may request investigational product—Manufacturer may make for treatment—Agreement. (1) An eligible patient and his or her treating physician may request that a manufacturer make an investigational product available for treatment of the patient. The request must include a copy of the written informed consent form described in RCW […]
69.70.900 – Effective date.
RCW 69.70.900 Effective date. This act takes effect July 1, 2014. [ 2013 c 260 § 12.]
69.75.010 – Definitions.
RCW 69.75.010 Definitions. The definitions in this section apply throughout this chapter unless the context clearly requires otherwise. (1) “Common carrier” means any person who holds himself or herself out to the general public as a provider for hire of the transportation by water, land, or air of merchandise, whether or not the person actually […]
69.70.020 – Donations of prescription drugs and supplies—Distribution.
RCW 69.70.020 Donations of prescription drugs and supplies—Distribution. (1) Any practitioner, pharmacist, medical facility, drug manufacturer, or drug wholesaler may donate prescription drugs and supplies to a pharmacy for redistribution without compensation or the expectation of compensation to individuals who meet the prioritization criteria established in RCW 69.70.040. Donations of prescription drugs and supplies may […]
69.70.030 – Immunity—Eligibility.
RCW 69.70.030 Immunity—Eligibility. To be eligible for the immunity in RCW 69.70.070, a person distributing donated prescription drugs under this chapter must: (1) Meet all requirements in RCW 69.70.050 and any applicable rules related to the return or exchange of prescription drugs or supplies adopted by the *board of pharmacy; (2) Maintain records of any […]
69.70.040 – Dispensing of donated prescription drugs and supplies—Priority given to individuals who are uninsured.
RCW 69.70.040 Dispensing of donated prescription drugs and supplies—Priority given to individuals who are uninsured. Pharmacies, pharmacists, and prescribing practitioners that elect to dispense donated prescription drugs and supplies under this chapter shall give priority to individuals who are uninsured. If an uninsured individual has not been identified as in need of available prescription drugs […]